Literature DB >> 24993059

Comparison of the outcomes of photodynamic therapy between two angiographic subtypes of polypoidal choroidal vasculopathy.

Shigeru Honda1, Akiko Miki, Suiho Yanagisawa, Wataru Matsumiya, Takayuki Nagai, Yasutomo Tsukahara.   

Abstract

BACKGROUND: To compare the outcomes of photodynamic therapy (PDT) between two different angiographic subtypes of polypoidal choroidal vasculopathy (PCV).
METHODS: Ninety-three consecutive cases of PCV were classified into two phenotypes (42 type 1 and 51 type 2) according to the presence or absence of feeding vessels found on indocyanine green angiography. Full-dose PDT and retreatments were performed every 3 months as needed based on the findings on angiography. The best-corrected visual acuity (BCVA) was compared as the main outcome between type 1 and type 2 PCV up to 12 months after the initial PDT.
RESULTS: The baseline greatest linear dimension (GLD) was significantly larger in type 1 PCV than type 2 PCV. The mean BCVA was significantly improved from baseline in type 2 PCV, while no improvement was found in type 1 PCV. Analysis with matching the GLD between both PCV subtypes did not change the original results.
CONCLUSIONS: There may be a significantly different response to PDT between two angiographic phenotypes of PCV.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24993059     DOI: 10.1159/000360308

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  12 in total

1.  Factors associated with polyp regression after intravitreal ranibizumab injections for polypoidal choroidal vasculopathy.

Authors:  Han Joo Cho; Sang Yoon Han; Hyoung Seok Kim; Tae Gon Lee; Jong Woo Kim
Journal:  Jpn J Ophthalmol       Date:  2014-11-07       Impact factor: 2.447

2.  Association of an age-related maculopathy susceptibility 2 gene variant with the 12-month outcomes of intravitreal aflibercept combined with photodynamic therapy for polypoidal choroidal vasculopathy.

Authors:  Shunichiro Nakai; Wataru Matsumiya; Akiko Miki; Shigeru Honda; Makoto Nakamura
Journal:  Jpn J Ophthalmol       Date:  2019-08-02       Impact factor: 2.447

3.  Polypoidal Choroidal Vasculopathy with Feeder Vessels: Characteristics, Fellow Eye Findings, and Long-term Treatment Outcomes.

Authors:  Hyun Ji Hwang; Jae Hui Kim; Young Suk Chang; Jong Woo Kim; Chul Gu Kim
Journal:  Korean J Ophthalmol       Date:  2017-05-12

4.  Association between pachychoroid and long-term treatment outcomes of photodynamic therapy with intravitreal ranibizumab for polypoidal choroidal vasculopathy.

Authors:  Keiko Azuma; Atsushi Okubo; Yoko Nomura; Hanpeng Zhou; Ryo Terao; Yohei Hashimoto; Kimiko Shimizu Asano; Kunihiro Azuma; Tatsuya Inoue; Ryo Obata
Journal:  Sci Rep       Date:  2020-05-20       Impact factor: 4.379

5.  Intravitreal aflibercept for exudative age-related macular degeneration with good visual acuity: 2-year results of a prospective study.

Authors:  Shinichi Sakamoto; Hidenori Takahashi; Yuji Inoue; Yusuke Arai; Satoru Inoda; Natsuko Kakinuma; Yujiro Fujino; Tatsuro Tanabe; Hidetoshi Kawashima; Yasuo Yanagi
Journal:  Clin Ophthalmol       Date:  2018-06-25

Review 6.  Polypoidal choroidal vasculopathy: An update on current management and review of literature.

Authors:  Amit Harishchandra Palkar; Vikas Khetan
Journal:  Taiwan J Ophthalmol       Date:  2019 Apr-Jun

7.  Comparison of clinical features and 3-month treatment response among three different choroidal thickness groups in polypoidal choroidal vasculopathy.

Authors:  Mingui Kong; Sung Min Kim; Don-Il Ham
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

Review 8.  Current management strategy of polypoidal choroidal vasculopathy.

Authors:  Christine P S Ho; Timothy Y Y Lai
Journal:  Indian J Ophthalmol       Date:  2018-12       Impact factor: 1.848

9.  Dynamic changes in choroidal conditions during anti-vascular endothelial growth factor therapy in polypoidal choroidal vasculopathy.

Authors:  Norihiro Nagai; Misa Suzuki; Sakiko Minami; Toshihide Kurihara; Mamoru Kamoshita; Hideki Sonobe; Kazuhiro Watanabe; Atsuro Uchida; Hajime Shinoda; Kazuo Tsubota; Yoko Ozawa
Journal:  Sci Rep       Date:  2019-08-06       Impact factor: 4.379

10.  Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy.

Authors:  Kikushima Wataru; Atsushi Sugiyama; Seigo Yoneyama; Mio Matsubara; Yoshiko Fukuda; Ravi Parikh; Yoichi Sakurada
Journal:  PLoS One       Date:  2020-02-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.